home                                                               

 

1.Trial for Inhalation Introduction of Glutoxim-Containing Formulation in Children Patients with COPD.

T.Y. Gembitskaya, M.A. Zaitseva, L.A. Kozhemyakin, A.V. Molodtsova

BAM R&D Laboratories, Ltd, Saint Petersburg, Russia

 

 

2. Glutoxim in complex therapy of tuberculosis.

G.B.Sokolova, M.V.Sinistyn, L.A.Kozhemyakin, M.I.Perelman I.M.Sechenov.
Moscow Medical Academy Phthysiopulmonology Research Institute,
Moscow ZAO “VAM — Research Laboratories”, St.-Petersburg.

 

3. Immunological changes in patients with pulmonary tuberculosis during glutoxim therapy.
Probl Tuberk. 2003;(7):42-7. [Article in Russian].
Knoring BE, Avetisian AO, El'kin AV, Kozhemiakin LA, Simbirtsev AS, Sakharova IIa, Loginova GP,
Pigareva NV, Levashev IuN.

 

4. Treatment of drug resistant tuberculosis
Antibiot Khimioter.
2003;48(8):28-36. [Article in Russian]
Perelman MI, Sokolova GB, Borisov SE, Kunichan AD, Lazareva IaV, Mozhokina GN, Elistratova NA, Tsybanev AA.
Research Institute of Phthisiopulmonary, I. M. Sechenov Moscow Medical Academy, Moscow.


5. Effect of glutoxim in the combination with antitubercular agents of the second choice on the growth of drug resistant Mycobacteria tuberculosis in the cultured murine lung tissue.
Antibiot Khimioter. 2002;47(6):18-21. [Article in Russian]
Kunichan AD, Sokolova GB, Perel'man MI.
Research Institute of Phthisiopulmonology,
I.M. Sechenov Moscow Medical Academy, Moscow.

 

6. Glutoxim in the complex treatment of tuberculosis
Antibiot Khimioter.
2002;47(2):20-23. [Article in Russian]
Sokolova GB, Sinitsyn MV, Kozhemiakin LA, Perelman MI.
Research Institute of Phthisiopulmonology, I. M. Sechenov Moscow Medical Academy, ZAO VAM-Research Laboratories, St-Peterburg.
 

home